Propanc Biopharma Inc. (PPCH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PPCH | AMGN | VRTX | REGN | BMY |
| Company | Propanc Biopharma Inc. | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 1.3000 | 278.16 | 392.81 | 877.00 | 44.28 |
| High | 1.4200 | 278.16 | 406.95 | 877.00 | 44.28 |
| Low | 1.3000 | 278.16 | 392.47 | 877.00 | 44.28 |
| Last | 1.3950 | 278.16 | 402.14 | 877.00 | 44.28 |
| Change | +0.1050 | +0.79 | +9.33 | -26.48 | +0.07 |
| % Change | +8.14% | +0.28% | +2.38% | -2.93% | +0.16% |
| Volume | 28,600 | 1,089 | 1,256,400 | 1,565 | 12,550 |
| 20-Day Average Volume | 42,490 | 2,120,534 | 999,495 | 456,123 | 13,516,463 |
| Previous Close | 1.2900 | 277.37 | 392.81 | 903.48 | 44.21 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.2912 | 270.19 | 398.90 | 906.13 | 47.86 |
| 20-Day Raw Stochastic | 48.37% | 91.23% | 51.46% | 2.38% | 6.94% |
| 20-Day Relative Strength | 44.56% | 53.50% | 47.81% | 35.66% | 29.10% |
| Weighted Alpha | -76.68 | +15.00 | +14.78 | +12.44 | -36.09 |
| Today's Opinion | N/A | 16% Sell | 8% Buy | 8% Sell | 88% Sell |
| Previous Opinion | N/A | 24% Sell | 24% Sell | 8% Buy | 88% Sell |
| Last Month's Opinion | N/A | 8% Sell | 40% Buy | 56% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +8.98% since 05/24/17 | +3.26% since 04/25/24 | +0.34% since 04/24/24 | -1.54% since 04/25/24 | -0.94% since 04/25/24 |
| Low | 1.1000 on 05/25/17 | 265.72 on 04/26/24 | 391.70 on 04/30/24 | 875.22 on 04/26/24 | 43.73 on 05/01/24 |
| High | 1.4200 on 05/31/17 | 279.84 on 05/01/24 | 406.95 on 05/01/24 | 913.21 on 05/01/24 | 45.38 on 04/29/24 |
| 1-Month | |||||
| %Chg | -29.19% since 04/28/17 | +0.71% since 04/02/24 | -4.36% since 04/01/24 | -8.14% since 04/02/24 | -16.04% since 04/02/24 |
| Low | 0.9500 on 05/11/17 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.73 on 05/01/24 |
| High | 1.9700 on 05/01/17 | 279.84 on 05/01/24 | 420.87 on 04/02/24 | 962.20 on 04/04/24 | 52.87 on 04/03/24 |
| 3-Month | |||||
| %Chg | -47.36% since 02/28/17 | -13.93% since 02/02/24 | -7.31% since 02/01/24 | -7.21% since 02/02/24 | -9.09% since 02/02/24 |
| Low | 0.9500 on 05/11/17 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.73 on 05/01/24 |
| High | 2.8750 on 03/03/17 | 329.72 on 02/05/24 | 437.00 on 02/27/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | -45.29% since 11/28/16 | +4.34% since 11/02/23 | +8.88% since 11/01/23 | +7.11% since 11/02/23 | -13.40% since 11/02/23 |
| Low | 0.9500 on 05/11/17 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 783.57 on 11/10/23 | 43.73 on 05/01/24 |
| High | 4.2500 on 12/07/16 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 5,231 | 148,774,592 | 103,936,712 | 99,167,768 | 89,618,088 |
| Shares Outstanding, K | 3,750 | 536,376 | 258,459 | 109,762 | 2,027,100 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -9,410,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 0 | 8,196,000,000 | 2,517,700,000 | 3,434,300,000 | 11,865,000,000 |
| Last Quarter Net Income | -1,370,000 | 767,000,000 | 968,800,000 | 1,159,600,000 | -11,911,000,000 |
| 60-Month Beta | 9.04 | 0.60 | 0.39 | 0.17 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 4.71 on 02/06/24 | 4.20 on 02/05/24 | 11.86 on 02/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 05/29/17 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.69 | 29.23 | 23.70 | 41.85 |